167 related articles for article (PubMed ID: 24400872)
1. Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity.
Dekaminaviciute D; Kairys V; Zilnyte M; Petrikaite V; Jogaite V; Matuliene J; Gudleviciene Z; Vullo D; Supuran CT; Zvirbliene A
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):804-10. PubMed ID: 24400872
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells.
Stravinskiene D; Sliziene A; Baranauskiene L; Petrikaite V; Zvirbliene A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321910
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX.
Zat'ovicová M; Tarábková K; Svastová E; Gibadulinová A; Mucha V; Jakubícková L; Biesová Z; Rafajová M; Ortova Gut M; Parkkila S; Parkkila AK; Waheed A; Sly WS; Horak I; Pastorek J; Pastoreková S
J Immunol Methods; 2003 Nov; 282(1-2):117-34. PubMed ID: 14604546
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of new monoclonal antibodies against human recombinant CA XII.
Dekaminaviciute D; Lasickiene R; Parkkila S; Jogaite V; Matuliene J; Matulis D; Zvirbliene A
Biomed Res Int; 2014; 2014():309307. PubMed ID: 24967350
[TBL] [Abstract][Full Text] [Related]
5. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA.
Del Prete S; Vullo D; De Luca V; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):906-11. PubMed ID: 24456295
[TBL] [Abstract][Full Text] [Related]
7. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase XII mRNA encodes a hydratase that is differentially expressed along the rabbit nephron.
Schwartz GJ; Kittelberger AM; Watkins RH; O'Reilly MA
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F399-410. PubMed ID: 12388401
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human carbonic anhydrase XII stability and inhibitor binding.
Jogaitė V; Zubrienė A; Michailovienė V; Gylytė J; Morkūnaitė V; Matulis D
Bioorg Med Chem; 2013 Mar; 21(6):1431-6. PubMed ID: 23159038
[TBL] [Abstract][Full Text] [Related]
10. Cloning, characterization and anion inhibition study of a β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.
Dedeoglu N; De Luca V; Isik S; Yildirim H; Kockar F; Capasso C; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2995-3001. PubMed ID: 26014482
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.
Gondi G; Mysliwietz J; Hulikova A; Jen JP; Swietach P; Kremmer E; Zeidler R
Cancer Res; 2013 Nov; 73(21):6494-503. PubMed ID: 24030978
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells.
Whittington DA; Waheed A; Ulmasov B; Shah GN; Grubb JH; Sly WS; Christianson DW
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9545-50. PubMed ID: 11493685
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.
Battke C; Kremmer E; Mysliwietz J; Gondi G; Dumitru C; Brandau S; Lang S; Vullo D; Supuran C; Zeidler R
Cancer Immunol Immunother; 2011 May; 60(5):649-58. PubMed ID: 21298264
[TBL] [Abstract][Full Text] [Related]
15. The catalytic properties of murine carbonic anhydrase VII.
Earnhardt JN; Qian M; Tu C; Lakkis MM; Bergenhem NC; Laipis PJ; Tashian RE; Silverman DN
Biochemistry; 1998 Jul; 37(30):10837-45. PubMed ID: 9692974
[TBL] [Abstract][Full Text] [Related]
16. Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
Carradori S; De Monte C; D'Ascenzio M; Secci D; Celik G; Ceruso M; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2013 Dec; 23(24):6759-63. PubMed ID: 24189056
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity.
Zvirbliene A; Pleckaityte M; Lasickiene R; Kucinskaite-Kodze I; Zvirblis G
Toxicon; 2010 Aug; 56(1):19-28. PubMed ID: 20298711
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
19. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
20. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
